Most centers also reported better patient satisfaction and engagement after initiation of transparency
MONDAY, Aug. 6, 2018 (HealthDay News) — Ambulatory surgery centers experience increases in patient volume, patient satisfaction, and revenue after adopting price transparency, according to a study published recently in The American Surgeon.
Ambar Mehta, M.D., from Johns Hopkins University in Baltimore, and colleagues used data from six ambulatory surgery centers to characterize the impact of price transparency on a surgery center’s patient volume, revenue, and patient satisfaction.
The researchers found that five centers reported an increase in patient volume and revenue after adopting price transparency, with a median increase of 50 percent in patient volume at one year (range, 10 to 200 percent). An increase in revenue (median 30 percent) was reported by four centers (range, 4 to 75 percent). Three centers reported an increase of new third-party administrator contracts (average; seven contracts; range, two to 12 contracts). Three centers reported a reduction in their administrative burden. Five of the six centers reported an increase in patient satisfaction and patient engagement after the initiation of price transparency. Discouragement from other practices, hospitals, or insurance companies was the leading barrier to making prices transparent.
“The findings of this study provide important insights to medical providers in designing and implementing price transparency initiatives,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Local Recurrence Rate Low After R0 Resection of Soft Tissue Sarcoma Tumors
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
2016 to 2024 Saw Increase in Patients Using Medical Cannabis
Early Complications Common in Older Kidney Transplant Recipients